EBO-PEP
Protecting high-risk contacts from developing Ebola Virus Disease (EVD)
About the project
The EBO-PEP project aims to strengthen the response capacity against Ebola Virus Disease by evaluating the effectiveness of a post-exposure prophylaxis (PEP) strategy among individuals identified as high-risk contacts.
The EBO-PEP project will
1
Conduct a multicenter, multi-epidemic Phase III clinical trial across several African countries to assess the efficacy of a monoclonal antibody (mAbs) therapy used in combination with vaccination, administered as PEP for high-risk contacts of EVD cases.
2
Strengthen the capacity of clinical researchers, while increasing knowledge and community engagement in Ebola research and medical response.
3
Define the optimal PEP strategy for high-risk contacts and advocate for its implementation in countries affected by EVD outbreaks.
Map
The project will be deployed during an EVD outbreak, as close as possible to active transmission zones. To achieve this, the EBO-PEP team will coordinate with national outbreak response operations in countries where Ebola is most likely to re-emerge, including the Democratic Republic of the Congo (DRC), Guinea, Sierra Leone, and/or Liberia, with support from ALIMA and MSF.
Additional countries may be included depending on future outbreak locations.
Key figures
0
Number of Ebola* epidemics worldwide since 1976 3
*All strains combined
- World Health Organization. Maladie à virus Ebola [Internet]. Genève : WHO; 2025 [cité 2025 Nov 27]. Available at : https://www.who.int/fr/news‑
room/fact‑sheets/detail/ebola‑ disease - Mercy Corps. African countries fighting Ebola outbreaks [Internet]. Mercy Corps; 2019 [cité 2025 Nov 27]. Available at : https://www.mercycorps.org/
blog/ebola-outbreaks-africa- guide/chapter-3 - Centers for Disease Control and Prevention. Ebola (Ebola virus disease) — Outbreaks [Internet]. Atlanta (GA) : CDC; [cité 2025 Nov 27]. Available at : https://www.cdc.gov/ebola/
outbreaks/index.html - Barbiero VK. Ebola: A Hyperinflated Emergency. Glob Health Sci Pract. 2020 Jun 30;8(2):178-182. DOI: 10.9745/GHSP-D-19-00422. PMID: 32430358; PMCID: PMC7326525.
Funders
This project 101145675 – EBO-PEP – HORIZON-JU-GHEDCTP3-2023-01 is supported by the Global Health EDCTP3 partnership.